Extracorporeal membrane oxygenation sales will grow through 2036, led by venoarterial systems at 47.8% of the modality segment in 2026. The market was valued at USD 535.40 million in 2025 and is expected to be worth USD 741.12 million by 2036, creating an incremental opportunity of USD 189.66 million.